GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes

This study has been terminated.
(The development program has been terminated)
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00252876
First received: November 10, 2005
Last updated: March 14, 2008
Last verified: March 2008
  Purpose

This is a 107-week open-label, multi-center long-term extension study from GALLANT studies 2/22, 5, 7, 8 and 14 to monitor the safety and tolerability of oral tesaglitazar 1 mg in patients with type 2 diabetes during up to 104 weeks of treatment. The total duration, including treatment and follow-up, is 107 weeks.


Condition Intervention Phase
Type 2 Diabetes
Drug: tesaglitazar
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Adverse events, laboratory variables, physical examination, cardiac evaluation, hypoglycemic events, electrocardiogram, vital signs (blood pressure and pulse), body weight

Secondary Outcome Measures:
  • Pharmacodynamic: fasting plasma glucose, glycosylated hemoglobin A1c, lipid variables (triglyceride, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol)
  • Responder rates and proportion of patients on tesaglitazar who reach pre-specified target levels for triglyceride, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol
  • C-reactive protein
  • Central obesity (waist circumference, hip circumference, waist/hip ratio)

Estimated Enrollment: 2000
Study Start Date: March 2005
Study Completion Date: January 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Provision of a written informed consent
  • Men or women who are >=18 years of age
  • Female patients: postmenopausal, hysterectomized, or if of childbearing potential, using a reliable method of birth control
  • Completed the last two visits of randomized treatment period in GALLANT 2/22, 5, 7, 8 or 14 studies.

Exclusion Criteria:

  • Type 1 diabetes
  • New York Heart Association heart failure Class III or IV
  • Treatment with chronic insulin
  • History of hypersensitivity or intolerance to any peroxisome proliferator-activated receptor agonist (like Actos or Avandia), fenofibrate, metformin or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin)
  • History of drug-induced myopathy or drug-induced creatine kinase elevation, liver enzyme elevations, neutropenia (low white blood cells)
  • Creatinine levels above twice the normal range
  • Creatine kinase above 3 times the upper limit of normal
  • Previous enrollment in this long-term extension study
  • Any clinically significant abnormality identified on physical examination, laboratory tests or electrocardiogram, which in the judgment of the investigator would compromise the patient's safety or successful participation in the clinical study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00252876

  Hide Study Locations
Locations
United States, Alabama
Research Site
Birmingham, Alabama, United States
Research Site
Columbiana, Alabama, United States
Research Site
Mobile, Alabama, United States
United States, Arkansas
Research Site
Carlisle, Arkansas, United States
Research Site
Sherwood, Arkansas, United States
United States, California
Research Site
Chula Vista, California, United States
Research Site
Escondido, California, United States
Research Site
Huntington Beach, California, United States
Research Site
Los Angeles, California, United States
Research Site
Mission Viejo, California, United States
Research Site
Orange, California, United States
Research Site
Pasadena, California, United States
Research Site
Redondo Beach, California, United States
Research Site
Sacramento, California, United States
United States, Colorado
Research Site
Colorado Springs, Colorado, United States
Research Site
Wheat Ridge, Colorado, United States
United States, Florida
Research Site
Clearwater, Florida, United States
Research Site
Gainesville, Florida, United States
Research Site
Hollywood, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Miami, Florida, United States
Research Site
West Palm Beach, Florida, United States
United States, Georgia
Research Site
Atlanta, Georgia, United States
Research Site
Brunswick, Georgia, United States
United States, Hawaii
Research Site
Honolulu, Hawaii, United States
United States, Idaho
Research Site
Boise, Idaho, United States
United States, Indiana
Research Site
Evansville, Indiana, United States
United States, Kansas
Research Site
Witchita, Kansas, United States
United States, Louisiana
Research Site
Bossier City, Louisiana, United States
Research Site
New Orleans, Louisiana, United States
United States, Maryland
Research Site
Baltimore, Maryland, United States
United States, Michigan
Research Site
Kalamazoo, Michigan, United States
United States, Nevada
Research Site
Las Vegas, Nevada, United States
Research Site
Pahrump, Nevada, United States
United States, New Jersey
Research Site
Hamilton, New Jersey, United States
United States, New Mexico
Research Site
Albuquerque, New Mexico, United States
United States, New York
Research Site
Bronx, New York, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
Research Site
White Plains, New York, United States
United States, North Carolina
Research Site
Charlotte, North Carolina, United States
United States, Ohio
Research Site
Cincinnati, Ohio, United States
Research Site
Dayton, Ohio, United States
Research Site
Kettering, Ohio, United States
United States, Oklahoma
Research Site
Oklahoma City, Oklahoma, United States
United States, Oregon
Research Site
Medford, Oregon, United States
United States, Pennsylvania
Research Site
Philadelphia, Pennsylvania, United States
United States, South Carolina
Research Site
Simpsonville, South Carolina, United States
United States, Tennessee
Research Site
Morristown, Tennessee, United States
United States, Texas
Research Site
Corpus Christi, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
San Antonio, Texas, United States
United States, Virginia
Research Site
Burke, Virginia, United States
Research Site
Norfolk, Virginia, United States
Research Site
Richmond, Virginia, United States
United States, Washington
Research Site
Tacoma, Washington, United States
United States, Wisconsin
Research Site
Menomonee Falls, Wisconsin, United States
Research Site
Milwaukee, Wisconsin, United States
Argentina
Research Site
Moron, Buenos Aires, Argentina
Research Site
Quilmes, Buenos Aires, Argentina
Research Site
Ciudad de Buenos Aires, Argentina
Research Site
Córdoba, Argentina
Research Site
Rosario, Argentina
Research Site
Salta - Salta, Argentina
Australia
Research Site
Adelaide, Australia
Research Site
Brisbane, Australia
Research Site
Cairns, Australia
Research Site
Geelong, Australia
Research Site
Melbourne, Australia
Research Site
Perth, Australia
Research Site
Sydney, Australia
Research Site
Tasmania, Australia
Brazil
Research Site
Curitiba, Brazil
Research Site
Fortaleza, Brazil
Research Site
Goiânia, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Ribeirão Preto, Brazil
Research Site
São Paulo, Brazil
Canada, Alberta
Research Site
Calgary, Alberta, Canada
Canada, British Columbia
Research Site
Coquitlam, British Columbia, Canada
Research Site
Surrey, British Columbia, Canada
Canada, Manitoba
Research Site
Winnipeg, Manitoba, Canada
Canada, Newfoundland and Labrador
Research Site
Bay Roberts, Newfoundland and Labrador, Canada
Research Site
Mount Pearl, Newfoundland and Labrador, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Canada, Ontario
Research Site
Bolton, Ontario, Canada
Research Site
Brampton, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Hastings, Ontario, Canada
Research Site
Kingston, Ontario, Canada
Research Site
London, Ontario, Canada
Research Site
Napanee, Ontario, Canada
Research Site
North York, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Smith Falls, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Canada, Quebec
Research Site
Chomedey-Laval, Quebec, Canada
Research Site
Laval, Quebec, Canada
Research Site
Montréal, Quebec, Canada
Research Site
Sherbrooke, Quebec, Canada
Czech Republic
Research Site
Brno, Czech Republic
Research Site
Hodonin, Czech Republic
Research Site
Hradec Kralove, Czech Republic
Research Site
Plzen, Czech Republic
Research Site
Praha 5, Czech Republic
Research Site
Pribram, Czech Republic
Research Site
Semily, Czech Republic
Research Site
Tabor, Czech Republic
Research Site
Usti nad Labem, Czech Republic
Estonia
Research Site
Paide, Estonia
Research Site
Pärnu, Estonia
Research Site
Tallinn, Estonia
Research Site
Tartu, Estonia
Research Site
Viljandi, Estonia
Finland
Research Site
Helsinki, Finland
Research Site
Hämeenlinna, Finland
Research Site
Imatra, Finland
Research Site
Joensuu, Finland
Research Site
Kokkola, Finland
Research Site
Kouvola, Finland
Research Site
Kuopio, Finland
Research Site
Lahti, Finland
Research Site
Mikkeli, Finland
Research Site
Oulu, Finland
Research Site
Pietarsaari, Finland
Research Site
Salo, Finland
Research Site
Seinajoki, Finland
Research Site
Tampere, Finland
Research Site
Turku, Finland
Research Site
Vaasa, Finland
Research Site
Vantaa, Finland
Former Serbia and Montenegro
Research Site
Belgrade, Former Serbia and Montenegro
Greece
Research Site
Athens, Greece
Research Site
Piraeus, Greece
Hong Kong
Research Site
Hong Kong, Hong Kong
Hungary
Research Site
Balatonfüred, Hungary
Research Site
Budapest, Hungary
Research Site
Győr, Hungary
Research Site
Kaposvár, Hungary
Research Site
Kecskemét, Hungary
Research Site
Miskolc, Hungary
Research Site
Siófok, Hungary
Research Site
Székesfehérvár, Hungary
India
Research Site
Bangalore, India
Research Site
Hyderabad, India
Research Site
Mumbai, India
Research Site
New Delhi, India
Indonesia
Research Site
Jakarta, Indonesia
Research Site
Malang, Indonesia
Israel
Research Site
Ashkelon, Israel
Research Site
Haifa, Israel
Research Site
Holon, Israel
Research Site
Jerusalem, Israel
Research Site
Rishon-Lezion, Israel
Research Site
Tel Aviv, Israel
Research Site
Tel Hashomer, Israel
Research Site
Zefat, Israel
Italy
Research Site
Arenzano, Italy
Research Site
Chiavari (GE), Italy
Research Site
Chieri, Italy
Research Site
Firenze, Italy
Research Site
Messina, Italy
Research Site
Milano, Italy
Research Site
Monteccio Emilia, Italy
Research Site
Napoli, Italy
Research Site
Padova, Italy
Research Site
Pescara, Italy
Research Site
Piacenza, Italy
Research Site
Pistoia, Italy
Research Site
Reggio Calabria, Italy
Research Site
Reggio Emilia, Italy
Research Site
Roma, Italy
Research Site
Scandiano, Italy
Research Site
Udine, Italy
Korea, Republic of
Research Site
Seoul, Korea, Republic of
Research Site
Suwon, Korea, Republic of
Latvia
Research Site
Daugavpils, Latvia
Research Site
Jekabpils, Latvia
Research Site
Madona, Latvia
Research Site
Riga, Latvia
Research Site
SIgulda, Latvia
Research Site
Talsi, Latvia
Research Site
Valmiera, Latvia
Lithuania
Research Site
Vilnius, Lithuania
Malaysia
Research Site
Kubang Kerian, Kota Bharu, Malaysia
Research Site
Kuala Lumpur, Malaysia
Research Site
Penang, Malaysia
Netherlands
Research Site
Beek en Donk, Netherlands
Research Site
Bennebroek, Netherlands
Research Site
Den Haag, Netherlands
Research Site
Deurne, Netherlands
Research Site
Huizen, Netherlands
Research Site
Losser, Netherlands
Research Site
Nijverdal, Netherlands
Research Site
Rijswijk, Netherlands
Research Site
Roelofarendsveen, Netherlands
Research Site
Rotterdam, Netherlands
Philippines
Research Site
Cebu City, Philippines
Research Site
Makati, Philippines
Research Site
Manila, Philippines
Research Site
Marikina City, Philippines
Research Site
Pasig City, Philippines
Research Site
Quezon City, Philippines
Poland
Research Site
Katowice, Ochojec, Poland
Research Site
Bialystok, Poland
Research Site
Bydgoszcz, Poland
Research Site
Gdansk, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Olsztyn, Poland
Research Site
Poznan, Poland
Research Site
Radom, Poland
Research Site
Rzeszow, Poland
Research Site
Sopot, Poland
Research Site
Szczecin, Poland
Research Site
Toruñ, Poland
Research Site
Tychy, Poland
Research Site
Warszawa, Poland
Research Site
Wroclaw, Poland
Research Site
Zielona Gora, Poland
Portugal
Research Site
Almada, Portugal
Research Site
Amadora, Portugal
Research Site
Elvas, Portugal
Research Site
Lisbon, Portugal
Research Site
Portalegre, Portugal
Russian Federation
Research Site
Moscow, Russian Federation
Research Site
St. Petersburg, Russian Federation
Research Site
Yaroslavl, Russian Federation
Singapore
Research Site
Singapore, Singapore
Slovakia
Research Site
Dolny Kubin, Slovakia
Research Site
Levice, Slovakia
Research Site
Lubochna, Slovakia
Research Site
Lucenec, Slovakia
Research Site
Nove Zamky, Slovakia
Research Site
Povazska Bystrica, Slovakia
Research Site
Sahy, Slovakia
Research Site
Trencin, Slovakia
Research Site
Velky Meder, Slovakia
Research Site
Zilina, Slovakia
South Africa
Research Site
Cape Town, South Africa
Research Site
Chatsworth, South Africa
Research Site
Durban, South Africa
Research Site
Gauteng, South Africa
Research Site
Johannesburg, South Africa
Research Site
Pretoria, South Africa
Switzerland
Research Site
Bern, Switzerland
Research Site
Ilanz, Switzerland
Research Site
Lausanne, Switzerland
Research Site
Monthey, Switzerland
Research Site
Zürich, Switzerland
United Kingdom
Research Site
Aberdeen, United Kingdom
Research Site
Atherstone, United Kingdom
Research Site
Ayr, United Kingdom
Research Site
Bath, United Kingdom
Research Site
Belfast, United Kingdom
Research Site
Berks, United Kingdom
Research Site
Birmingham, United Kingdom
Research Site
Bolton, United Kingdom
Research Site
Bucks, United Kingdom
Research Site
Cardiff, United Kingdom
Research Site
Coventry, United Kingdom
Research Site
Dundee, United Kingdom
Research Site
Edinburgh, United Kingdom
Research Site
Glasgow, United Kingdom
Research Site
Leeds, United Kingdom
Research Site
Liverpool, United Kingdom
Research Site
Manchester, United Kingdom
Research Site
Northampton, United Kingdom
Research Site
Plymouth, United Kingdom
Research Site
Radstock, United Kingdom
Research Site
Shrewsbury, United Kingdom
Research Site
Surrey, United Kingdom
Research Site
West Bromwich, United Kingdom
Research Site
Wiltshire, United Kingdom
Research Site
Wrexham, United Kingdom
Vietnam
Research Site
Hanoi, Vietnam
Research Site
Ho Chi Minh, Vietnam
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: AstraZeneca Galida Medical Science Director, MD AstraZeneca
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00252876     History of Changes
Other Study ID Numbers: D6160C00038, GALLEX 1
Study First Received: November 10, 2005
Last Updated: March 14, 2008
Health Authority: United Kingdom: Department of Health

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 28, 2014